Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × VP-102 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

pembrolizumab 1102 Specimen Handling 739 Carboplatin 725 Cyclophosphamide 704 Magnetic Resonance Spectroscopy 688 Cisplatin 625 Nivolumab 602 Paclitaxel 548 Radiotherapy 491 Gemcitabine 480 Biopsy 451 Bevacizumab 408 Dexamethasone 392 fludarabine 347 Docetaxel 341 venetoclax 336 Fluorouracil 320 Oxaliplatin 320 atezolizumab 316 Capecitabine 315 Rituximab 307 durvalumab 293 Doxorubicin 274 Radiosurgery 271 Pemetrexed 269 Drug Therapy 266 Ipilimumab 266 Standard of Care 259 Lenalidomide 251 Radiation 250

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07246590 2026-01-21

COVE-2

Verrica Pharmaceuticals Inc.

Phase 3 Recruiting

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡